Small-molecule CEM3 strengthens single-cell oscillators in the suprachiasmatic nucleus

被引:0
|
作者
van Beurden, Anouk W. [1 ]
Tersteeg, Mayke M. H. [1 ]
Michel, Stephan [1 ]
van Veldhoven, Jaco P. D. [2 ]
Ijzerman, Adriaan P. [2 ]
Rohling, Jos H. T. [1 ]
Meijer, Johanna H. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands
[2] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Leiden, Netherlands
来源
FASEB JOURNAL | 2024年 / 38卷 / 01期
基金
欧洲研究理事会;
关键词
CEM3; PER2; rhythm amplitude; small molecule; suprachiasmatic nucleus; synchrony; CIRCADIAN-RHYTHMS; CLOCK; MODULATORS; NEURONS; MOUSE;
D O I
10.1096/fj.202300597RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A robust endogenous clock is required for proper function of many physiological processes. The suprachiasmatic nucleus (SCN) constitutes our central circadian clock and allows us to adapt to daily changes in the environment. Aging can cause a decline in the amplitude of circadian rhythms in SCN and peripheral clocks, which contributes to increased risk of several chronic diseases. Strengthening clock function would therefore be an effective strategy to improve health. A high-throughput chemical screening has identified clock-enhancing molecule 3 (CEM3) as small molecule that increases circadian rhythm amplitude in cell lines and SCN explants. It is, however, currently not known whether CEM3 acts by enhancing the amplitude of individual single-cell oscillators or by enhancing synchrony among neurons. In view of CEM3's potential, it is of evident importance to clarify the mode of action of CEM3. Here, we investigated the effects of CEM3 on single-cell PERIOD2::LUCIFERASE rhythms in mouse SCN explants. CEM3 increased the amplitude in approximately 80%-90% of the individual cells in the SCN without disrupting the phase and/or period of their rhythms. Noticeably, CEM3's effect on amplitude is independent of the cell's initial amplitude. These findings make CEM3 a potential therapeutic candidate to restore compromised amplitude in circadian rhythms and will boost the development of other molecular approaches to improve health. Circadian rhythms are generated by the suprachiasmatic nucleus (SCN). Disruption of rhythms is a causal risk factor for the development of diseases, like depression or immune disorders. The small-molecule CEM3 strengthens SCN rhythms by enhancement of amplitude. We asked whether amplitude enhancement is a single-cell or a network phenomenon. The results indicate that CEM3 operates by increasing the amplitude of individual SCN neurons. This makes CEM3 an interesting therapeutic candidate for improving health by strengthening our internal clock.image
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Small-Molecule Inhibitor of Glycogen Synthase Kinase 3β 6-Bromoindirubin-3-oxime Inhibits Hematopoietic Regeneration in Stem Cell Recipient Mice
    Shen, Sylvie
    Xu, Ning
    Klamer, Guy
    Ko, Kap-Hyoun
    Khoo, Melissa
    Ma, David
    Moore, John
    O'Brien, Tracey A.
    Dolnikov, Alla
    STEM CELLS AND DEVELOPMENT, 2015, 24 (06) : 724 - 736
  • [32] Small-molecule MX-C2/3 suppresses non-small cell lung cancer progression via p53 activation
    Li, Liangping
    Du, Wenqing
    Wang, Hui
    Zhao, Yufei
    Huang, Zetian
    Peng, Yan
    Zeng, Shulan
    Zhang, Guohai
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 366
  • [33] An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects
    Siddiquee, Khandaker A. Z.
    Gunning, Patrick T.
    Glenn, Matthew
    Katt, William P.
    Zhang, Shumin
    Schroeck, Christopher
    Sebti, Said M.
    Jove, Richard
    Hamilton, Andrew D.
    Turkson, James
    ACS CHEMICAL BIOLOGY, 2007, 2 (12) : 787 - 798
  • [34] Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models
    Ma, Shuaiya
    Tian, Ye
    Peng, Jiali
    Chen, Chaojia
    Peng, Xueqi
    Zhao, Fabao
    Li, Zhenyu
    Li, Mengzhen
    Zhao, Fangcheng
    Sheng, Xue
    Zong, Runzhe
    Li, Yiquan
    Zhang, Jiwei
    Yu, Mingyan
    Zhu, Qingfen
    Tian, Xiaoyu
    Li, Yuyang
    Neckenig, Markus R.
    Liu, Huiqing
    Zhan, Peng
    Yue, Xuetian
    Wu, Zhuanchang
    Gao, Lifen
    Liang, Xiaohong
    Liu, Xinyong
    Li, Chunyang
    Ma, Chunhong
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (722)
  • [35] Single-cell transcriptome analysis of NEUROG3+cells during pancreatic endocrine differentiation with small molecules
    Li, Jin
    Chen, Junru
    Luo, Xiaoyu
    Lu, Guangxiu
    Lin, Ge
    STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
  • [36] Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with small molecules
    Jin Li
    Junru Chen
    Xiaoyu Luo
    Guangxiu Lu
    Ge Lin
    Stem Cell Research & Therapy, 14
  • [37] C188-9, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma
    Di, Jian-Xin
    Zhang, Hong-Yan
    ANTI-CANCER DRUGS, 2019, 30 (08) : 846 - 853
  • [38] Data Descriptor: High content screen for identifying small-molecule LC3B-localization modulators in a renal cancer cell line
    Kolla, Likhitha
    Heo, David S.
    Rosenberg, Daniel P.
    Barlow, Sara A.
    Maximova, Anna A.
    Cassio, Emily E.
    Buchser, William J.
    SCIENTIFIC DATA, 2018, 5
  • [39] Discovery of a novel small-molecule activator of SIRT3 that inhibits cell proliferation and migration by apoptosis and autophagy-dependent cell death pathways in colorectal cancer
    Mou, Yi
    Chen, Yanmei
    Fan, Zhichao
    Ye, Liansong
    Hu, Bing
    Han, Bo
    Wang, Guan
    BIOORGANIC CHEMISTRY, 2024, 146
  • [40] Advancing precision medicine combination drug screening: A miniaturized single-cell imaging platform for evaluating immunotherapy-small molecule combination therapeutics in individuals
    Jacob, Thomas
    Yan, Yunqi
    Kosaka, Yoko
    Jena, Sophia
    Kurtz, Stephen E.
    Kaempf, Andy
    Mori, Tomi
    Chang, Young Hwan
    Chang, Bill H.
    Borate, Uma
    Traer, Elie
    McWeeney, Shannon K.
    Martin, Jody
    Tyner, Jeffrey W.
    Lind, Evan F.
    Vu, Tania Q.
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 21 - 22